Colombia vs Cuba: The number of people with susceptibility test result for rifampicin
Colombia
39.17
in 2021
Cuba
40.43
in 2021
Colombia rank
125th
Cuba rank
124th
The number of people with susceptibility test result for rifampicin over time
- Colombia
- Cuba
How they compare
Cuba currently reports 40.43 against 39.17 in Colombia, a difference of 1.26.
Across all 5 years both countries report, Cuba has been ahead every year.
Colombia ranks 125th and Cuba ranks 124th of 146 countries.
Cuba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.03 | 66.38 | 44.35 | Cuba |
| 2020s | 29.98 | 45.55 | 15.57 | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Colombia or Cuba?
- Cuba, at 40.43 against 39.17 in Colombia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Colombia and Cuba?
- 1.26, with Cuba ahead.
- How many years of comparable data are there for Colombia and Cuba?
- 5 years are reported by both, from 2017 to 2021.
- How do Colombia and Cuba rank globally for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 125th and Cuba ranks 124th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.